Operationalization and implementation of pharmacological treatments - PowerPoint PPT Presentation

Panel / Audience Discussion Operationalization and implementation of pharmacological treatments for acutely suicidal patients: Insight from the trenches Moderator: Suresh Durgam, MD Panel: Wieslaw Cubala, MD, PhD Dong-Jing Fu, MD, PhD Jonathan Javitt, MD, MPH Emilie Olie, MD, PhD 1

Panel: Disclosures Suresh Durgam, MD Shares: Intra-Cellular Therapies, Inc Paid position: Intra-Cellular Therapies, Inc 2

Panel: Disclosures Wieslaw Jerzy Cubala, MD, PhD Grants: Alkermes, Auspex Pharmaceuticals, BMS, Celon, Cephalon, Ferrier, Forest Laboratories, GedeonRichter, GWPharmaceuticals, Janssen, KCR, Lilly, Lundbeck, Minerva, NIH, Orion, Otsuka, Sanofi, Servier Honoraria: Adamed, Angelini, AstraZeneca, BMS, Celon, GSK, KRKA, Lekam, Lundbeck, Minerva, NeuroCog, Novartis, Orion, Pfizer, Polfa Tarchomin, Sanofi, Servier, Zentiva Shares: PBKM Advisory boards: Janssen, Sanofi Dong Jing (DJ) Fu, MD, PhD Shares: Johnson & Johnson Paid position: Director, Clinical Development, Janssen R&D, LLC Jonathan Javitt, MD, MPH Shares: NeuroRx, Inc. Paid position: CEO and Chairman, NeuroRx, Inc. Other involvement: Adj. Professor, Johns Hopkins University School of Medicine Emilie Olié, MD, PhD Grants: AstraZeneca, institut UPSA de la Douleur Honoraria: AstraZeneca, BMS, Lundbeck, Janssen Cilag, Otsuka Advisory boards: Janssen Cilag 3